Two new studies demonstrate the impact of respiratory syncytial virus (RSV) in different populations, with one showing that ...

The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...

The medicines regulator has flagged up a small increased risk of Guillain-Barré syndrome after RSV vaccination in adults over ...

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

With the 2025 influenza season starting earlier than usual, the NICD urges South Africans to stay vigilant against seasonal ...

RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...

As many as 20 people developed a potentially paralysing illness after getting the respiratory syncytial virus (RSV) vaccine.

Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a quiet update ...

Stratified analyses revealed a notable increase in risk among cancer survivors aged 50 years or older at baseline (aHR, 1.85) ...

Vaccination programs have saved lives – and saved the Canadian economy and health care system significant resources as well ...